PMS2 and cervical carcinoma: Because phosphorylation of s9 is known to inactivate GSK-3β kinase activity and can be used as a measurement of inactivation, we compared expression of MLH1, MSH2, and PMS2 with pGSK-3β(s9) level in cervical carcinoma.